Folgen
Pinar Kanlikilicer
Pinar Kanlikilicer
Bestätigte E-Mail-Adresse bei mdanderson.org
Titel
Zitiert von
Zitiert von
Jahr
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ...
EBioMedicine 38, 100-112, 2018
1842018
The extracellular RNA communication consortium: establishing foundational knowledge and technologies for extracellular RNA research
S Das, AB Abdel-Mageed, C Adamidi, PD Adelson, KM Akat, E Alsop, ...
Cell 177 (2), 231-242, 2019
1822019
Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells
P Kanlikilicer, MH Rashed, R Bayraktar, R Mitra, C Ivan, B Aslan, X Zhang, ...
Cancer research 76 (24), 7194-7207, 2016
1312016
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
R Bayraktar, M Pichler, P Kanlikilicer, C Ivan, E Bayraktar, N Kahraman, ...
Oncotarget 8 (7), 11641, 2017
1232017
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma
AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ...
Cellular signalling 68, 109539, 2020
942020
Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
B Marc D., S Andreia M., P Kanlikilicer-Unaldi, J Filant, MH Rashed, ...
Non-Coding RNA 1 (1), 53-68, 2015
942015
Dual suppressive effect of miR-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion
R Bayraktar, C Ivan, E Bayraktar, P Kanlikilicer, NN Kabil, N Kahraman, ...
Clinical Cancer Research 24 (17), 4225-4241, 2018
802018
Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer
V Gonzalez-Villasana, E Fuentes-Mattei, C Ivan, HJ Dalton, ...
Clinical cancer research 21 (9), 2127-2137, 2015
802015
Therapeutic targeting of AXL receptor tyrosine kinase inhibits tumor growth and intraperitoneal metastasis in ovarian cancer models
P Kanlikilicer, B Ozpolat, B Aslan, R Bayraktar, N Gurbuz, ...
Molecular Therapy-Nucleic Acids 9, 251-262, 2017
632017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs
MH Rashed, P Kanlikilicer, C Rodriguez-Aguayo, M Pichler, R Bayraktar, ...
Oncotarget 8 (12), 20145, 2017
622017
The ZNF304-integrin axis protects against anoikis in cancer
B Aslan, P Monroig, MC Hsu, GA Pena, C Rodriguez-Aguayo, ...
Nature communications 6 (1), 7351, 2015
592015
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
A Gorur, R Bayraktar, C Ivan, HA Mokhlis, E Bayraktar, N Kahraman, ...
Molecular Therapy-Nucleic Acids 23, 930-943, 2021
342021
The modulatory role of MicroRNA-873 in the progression of KRAS-driven cancers
HA Mokhlis, R Bayraktar, NN Kabil, A Caner, N Kahraman, ...
Molecular Therapy-Nucleic Acids 14, 301-317, 2019
302019
Investigating the effect of perinatal nicotine exposure on dopaminergic neurons in the VTA using miRNA expression profiles
RF Keller, P Kanlikilicer, A Dragomir, Y Fan, YM Akay, M Akay
IEEE transactions on nanobioscience 16 (8), 843-849, 2017
202017
Communication between the active site and the allosteric site in class A beta-lactamases
D Meneksedag, A Dogan, P Kanlikilicer, E Ozkirimli
Computational Biology and Chemistry 43, 1-10, 2013
182013
Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure
P Kanlikilicer, D Zhang, A Dragomir, YM Akay, M Akay
Medical & biological engineering & computing 55, 467-482, 2017
162017
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018; 38: 100–12
P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ...
Epub 2018/11/30. https://doi. org/10.1016/j. ebiom. 2018.11. 004 PMID: 30487062, 0
9
Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’[EBioMedicine 38 (2018) 100–112]
P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ...
EBioMedicine 52, 2020
62020
Exosome-related methods and potential use as vaccines
P Kanlikilicer
Cancer Immunoprevention: Methods and Protocols, 35-41, 2022
32022
CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma (Cellular Signalling (2020) 68 …
AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ...
Cellular Signalling 89, 110147, 2022
32022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20